Key Financial’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-50
Closed -$119 – 1203
2022
Q4
$119 Hold
50
– – ﹤0.01% 1146
2022
Q3
$0 Buy
+50
New +$146 ﹤0.01% 1163

Other funds holding PBYI

Key Financial's PBYI Position: Q1 2023 in Review

Key Financial sold out of Puma Biotechnology (PBYI) in Q1 2023, closing a stake of 50 shares — an estimated $119 sold.

Key Financial first reported a position in PBYI in Q3 2022 and held it in 2 quarters. The position peaked at $119 in Q4 2022. 77 funds tracked by Wall St. Rank hold PBYI as of Q1 2023.

  • Key Financial reported no remaining Puma Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Key Financial sold 50 Puma Biotechnology shares in Q1 2023, an estimated $119.
  • Key Financial first reported a position in Puma Biotechnology in Q3 2022 and held it in 2 quarters.
  • Key Financial's Puma Biotechnology position peaked at $119 in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2023.

Based on Key Financial's 13F filing for Q1 2023, filed 2 May 2023.